• Publications
  • Influence
Pharmacy benefits and the use of drugs by the chronically ill.
CONTEXT Many health plans have instituted more cost sharing to discourage use of more expensive pharmaceuticals and to reduce drug spending. OBJECTIVE To determine how changes in cost sharingExpand
  • 532
  • 30
  • PDF
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
CONTEXT Prescription drugs are instrumental to managing and preventing chronic disease. Recent changes in US prescription drug cost sharing could affect access to them. OBJECTIVE To synthesizeExpand
  • 712
  • 20
  • PDF
Male urethral stricture disease.
PURPOSE The incidence of urethral stricture disease in the United States is unknown. We estimated the impact of urethral stricture disease by determining its prevalence, costs and other measures ofExpand
  • 334
  • 20
Urologic diseases in America Project: analytical methods and principal findings.
PURPOSE The burden of urological diseases on the American public is immense in human and financial terms but it has been under studied. We undertook a project, Urologic Diseases in America, toExpand
  • 202
  • 10
Consequences of health trends and medical innovation for the future elderly.
Recent innovations in biomedicine seem poised to revolutionize medical practice. At the same time, disease and disability are increasing among younger populations. This paper considers how theseExpand
  • 162
  • 10
  • PDF
Urologic Diseases in America Project
  • 274
  • 9
Employer drug benefit plans and spending on prescription drugs.
CONTEXT With drug spending rising rapidly for working-aged adults, many employers and health insurance providers have changed benefits packages to encourage use of fewer or less expensive drugs. ItExpand
  • 238
  • 7
  • PDF
Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy.
OBJECTIVE To determine whether a pharmacy benefit that varies copayments for cholesterol-lowering (CL) therapy according to expected therapeutic benefit would improve compliance and reduce use ofExpand
  • 177
  • 7
Benefit design and specialty drug use.
In this paper we examine spending by privately insured patients with four conditions often treated with specialty drugs: cancer, kidney disease, rheumatoid arthritis, and multiple sclerosis. DespiteExpand
  • 115
  • 6
Disability Forecasts and Future Medicare Costs
The traditional focus of disability research has been on the elderly, with good reason. Chronic disability is much more prevalent among the elderly, and it has a more direct impact on the demand forExpand
  • 54
  • 6
  • PDF